Home › NDC Lookup › RxCUI directory › RxCUI 2613956

Chloroprocaine hydrochloride 0.03 MG/MG Ophthalmic Gel — RxCUI 2613956

RxNorm drug concept · Semantic clinical drug
RxCUI 2613956 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2613956
Official nameChloroprocaine hydrochloride 0.03 MG/MG Ophthalmic Gel
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known aschloroprocaine hydrochloride 3 % Ophthalmic Gel; chloroprocaine hydrochloride 24 MG per 800 MG Ophthalmic Gel
FDA products mapped1
Package NDCs mapped3
Reported Medicaid activity (SDUD)2,907 prescriptions · 12 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Chloroprocaine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Chloroprocaine is a local anesthetic — it numbs a specific part of your body so you don't feel pain during a procedure. Depending on the product and strength, it can be used for si...
  • What exactly is chloroprocaine used for?
  • Yes — chloroprocaine is a local or regional anesthetic, not a general anesthetic. It numbs the targeted area but does not make you unconscious. You'll be awake and aware, just unab...
  • Chloroprocaine works quickly — usually within 6 to 12 minutes — and the numbing typically lasts up to about an hour, depending on how much is used and where it's given. It's actual...
📖 Read our full Chloroprocaine guide →

🕸️ Concept Web — How Chloroprocaine hydrochloride 0.03 MG/MG Ophthalm... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Chloroprocaine hydrochloride 0.03 MG/MG Ophthalmic Gel RxCUI 2613956

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Chloroprocaine 20859
    • Chloroprocaine hydrochloride 53616
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Iheezo 2613957
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Chloroprocaine Ophthalmic Gel 2613955
    • Chloroprocaine hydrochloride Ophthalmic Gel 2646295
    • Chloroprocaine Ophthalmic Product 2613954
    • Chloroprocaine hydrochloride Ophthalmic Product 2660897
    • Chloroprocaine Ophthalmic Gel [Iheezo] 2613960
    • Chloroprocaine hydrochloride Ophthalmic Gel [Iheezo] 2657901
    • Iheezo Ophthalmic Product 2613959
    • Ophthalmic Gel 316963
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Chloroprocaine hydrochloride 0.03 MG/MG SCDC · 2613953
  • Chloroprocaine Ophthalmic Gel SCDF · 2613955
  • Chloroprocaine hydrochloride Ophthalmic Gel SCDFP · 2646295
  • Chloroprocaine Ophthalmic Product SCDG · 2613954
  • Chloroprocaine hydrochloride Ophthalmic Product SCDGP · 2660897

Brand-Name Concepts

  • Chloroprocaine hydrochloride 0.03 MG/MG Ophthalmic Gel [Iheezo] SBD · 2613961
  • Chloroprocaine hydrochloride 0.03 MG/MG [Iheezo] SBDC · 2613958
  • Chloroprocaine Ophthalmic Gel [Iheezo] SBDF · 2613960
  • Chloroprocaine hydrochloride Ophthalmic Gel [Iheezo] SBDFP · 2657901
  • Iheezo Ophthalmic Product SBDG · 2613959
  • Iheezo BN · 2613957

📦 FDA Products & Package NDCs

1 product · 3 package NDCs
3 package NDCs map to RxCUI 2613956 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
82667-0300-00 1 POUCH in 1 CARTON (82667-300-00) / 1 VIAL in 1 POUCH / 80... IHEEZO Harrow Eye, LLC 2023-03-15
82667-0300-01 1 POUCH in 1 CARTON (82667-300-01) / 1 VIAL in 1 POUCH / 80... IHEEZO Harrow Eye, LLC 2022-09-27
82667-0300-05 5 POUCH in 1 CARTON (82667-300-05) / 1 VIAL in 1 POUCH / 80... IHEEZO Harrow Eye, LLC 2026-03-02
Observed labelers: Harrow Eye, LLC (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
J2403 Chloroprocaine opht gel, 1mg 2 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.